First-Line β-Blocker Use for Hypertension in the Veterans Health Administration
In this cross-sectional study, most veterans using β-blockers as a first-line treatment for hypertension did not have compelling indications, and several factors were associated with likelihood of β-blocker initiation in this group. Interventions are needed to improve initial guideline-concordant treatment for veterans with incident hypertension.
Authors
- William C. Cushman (ORCID: https://orcid.org/0000-0001-7162-2972)
- Sridharan Raghavan (ORCID: https://orcid.org/0000-0003-0643-4873)
- April F. Mohanty (ORCID: https://orcid.org/0000-0003-4510-9758)
- Leah Rethy (ORCID: https://orcid.org/0000-0001-8046-6895)
- Joshua A. Jacobs (ORCID: https://orcid.org/0000-0002-9621-9060)
- Catherine G. Derington (ORCID: https://orcid.org/0000-0001-7382-4607)
- Susan Zickmund (ORCID: https://orcid.org/0000-0002-1752-9811)
- Yizhe Xu (ORCID: https://orcid.org/0000-0002-0773-1709)
- Ransmond O. Berchie (ORCID: https://orcid.org/0000-0001-6883-6822)
- P. Michael Ho (ORCID: https://orcid.org/0000-0002-7775-6266)
- Adam P. Bress (ORCID: https://orcid.org/0000-0002-2259-5039)
- Jordan B. King (ORCID: https://orcid.org/0000-0002-6783-7951)
- Jordana B. Cohen (ORCID: https://orcid.org/0000-0003-4649-079X)
Institutions
- Intermountain Healthcare (US)
- Kaiser Permanente (US)
- University of Tennessee Health Science Center (US)
- Hospital of the University of Pennsylvania (US)
- Spencer Foundation (US)
- Colorado Permanente Medical Group (US)
- VA Eastern Colorado Health Care System (US)
- George E. Wahlen Department of VA Medical Center (US)
- University of Colorado Anschutz Medical Campus (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.29026
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00